ACCESS Newswire Inc.: ACCESS Newswire Expands the Marketplace with Two New Partners: TVEyes and Listicle Liaison

ACCESS Newswire Inc. (NYSE American: ACCS) added TVEyes and Listicle Liaison to its Marketplace, expanding broadcast, radio, and AI-citation visibility for customers. TVEyes offers media intelligence, while Listicle Liaison provides industry rankings and editorial placements. Both partnerships aim to enhance ACCESS's service offerings, according to the company.

Original reporting
Published Aug 31, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 31, 2026, 4:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$ACCS
Bullish
medium confidence
Mentioned
$ACCS
Relevance
4/10
AlphAI data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$ACCSBullishLow
01

Why it matters

The new partners target two monitoring gaps: broadcast and radio coverage (TVEyes) and evergreen rankings plus AI citation visibility (Listicle Liaison). The release positions these as complementary to ACCESS Verified metadata and citation scripts.

02

Market read

For ACCS, this is a go-to-market ecosystem expansion with a specific start date, but it lacks quantified financial impact.

03

What to watch

Traders may want to verify whether the partnerships are revenue-share, reseller, or integration-led, and whether they meaningfully change churn or ARPU for ACCS customers.

Relevance 4/10Novelty 4/10Timing: Marketplace availability begins September 1, 2026.

Background

ACCESS Newswire operates a PR and investor-relations platform with brand and social monitoring, and now expands its Marketplace with third-party capabilities.

Company-level read

Ticker impact

$ACCSBullishMedium confidence
Context

ACCESS Newswire announced two new Marketplace partners, TVEyes and Listicle Liaison, available starting September 1, 2026.

Expected impact

Likely modest, near-term sentiment lift; magnitude uncertain without disclosed contract economics.

Evidence & confidence

The article is a product ecosystem expansion for ACCS with a clear go-live date, yet it provides no guidance, pricing, or quantified customer impact.

Market effects

PR and investor-relations software providers may face incremental competitive pressure to broaden monitoring and AI-citation workflows.

No clear regional market linkage beyond the company’s US listing.

Partnerships are described as global, potentially supporting broader international demand for communications intelligence tools.

Counterpoint

Without disclosed financial terms or customer traction, the partnership may be more marketing than material earnings driver.

Key entities

  • ACCESS Newswire Inc.

    Subject of the announcement, expanding its Marketplace with TVEyes and Listicle Liaison.

  • TVEyes

    Broadcast and radio monitoring service providing indexed transcripts, clips, and reach metrics.

  • Listicle Liaison

    Visibility service focused on curated industry rankings and AI citation-ready editorial placements.

Related articles

$ACCSMed

ACCESS Newswire (ACCS) Q2 2026 Earnings Call Transcript

Access Newswire (ACCS) reported Q2 2026 total revenue of $5.6 million, up 5% sequentially and flat vs Q2 2025. Subscription ARR per customer rose to $12,718 (+15% YoY). Gross margin was 73% and operating loss $307,000. Adjusted EBITDA was $0.6 million. Cash was just under $3 million; it repurchased 40,000 shares.

$ACCSMed

ACCESS Newswire Reports Second Quarter 2026 Results

ACCESS Newswire Inc. (ACCS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ACCESS Newswire Reports Second Quarter 2026 Results Average ARR and cashflow from operations continue to increase over PY, as Adjusted EBITDA remains positive · Average ARR for subscriptions per customer at the end of Q2 2026 increased to $12,718, up from $11,039 at

$ACCSMed

ACCESS Newswire Inc.: ACCESS Newswire Reports Second Quarter 2026 Results

ACCESS Newswire Inc. (NYSE American:ACCS) reported Q2 2026 results: revenue rose to $5.6M from $5.3M in Q1 2026 and matched Q2 2025. Gross margin fell to 73% from 76% in Q2 2025. Adjusted EBITDA was $642k versus $836k a year earlier. Average ARR per subscription customer increased to $12,718. The company also reported a Q2 operating loss of $0.3M and cash flow from operations of $173k.

$XNCRHighAI 8/10

Xencor reports phase 1 data for cancer drug XmAb819

Xencor Inc. (XNCR) reported Phase 1 trial results for XmAb819, a cancer drug, showing a 45.5% response rate at the 400 mcg/kg dose. The company plans to discuss accelerated approval with the FDA and initiate a global trial comparing XmAb819 with tivozanib. Adverse events were reported in 72.1% of patients, with liver enzyme elevations being the most common.

$XNCRMedAI 8/10

A cancer drug shrank tumors in 5 of 11 patients; 82% were estimated to be alive without worsening cancer at six months.

Xencor presented Phase 1 data for XmAb819, showing tumor shrinkage in 5 of 11 advanced ccRCC patients. The company plans FDA discussions for accelerated approval in 2027. XmAb819 demonstrated a 45% confirmed objective response rate in heavily pre-treated patients. Xencor will host a webcast to discuss the results and development plans.